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&Bungarotoxin @Butx) is a presynaptically active neurotoxin which blocks neuronal A-type K+ channels. Here, the 
efficient solubilisation and about 300-fold purification of the b-Butx-binding protein from chick brain were achieved by 
detergent extraction at high ionic strength followed by chromatography on DEAE Athgel Blue, p-Butx Athgel 102 and 
wheat germ agglutinin Sepharose. Binding of 1251-labelled &Butx to the purified protein was inhibited by two other K+ 
channel igands, dendrotoxin I and mast cell-degranulating peptide. It is concluded that the p-Butx-binding protein is 
a member of a family of voltage-gated K+ channels which exhibit varying affinities for different polypeptide ligands. 
/I-Bungarotoxin; Dendrotoxin; Mast cell-degranulating peptide; K+ channel; (Chick brain) 
1. INTRODUCTION 
K+ channels are found in many animal tissues 
and represent a highly diverse family of membrane 
proteins. In excitable cells, voltage-dependent A- 
type K+ channels control the duration of action 
potentials, cardiac pace-making and neuro- 
transmitter release from presynaptic nerve ter- 
minals [ 11. Due to the availability of channel 
mutants [2] and specific neurotoxins [3], A-type 
K+ channels have recently become the object of in- 
tense biochemical and molecular genetic analysis. 
In Drosophila, functionally different A-type chan- 
nels have been shown to result from alternative 
splicing of the highly complex ‘shaker’ gene locus 
[4,5]. For the mammalian brain, evidence for 
heterogeneity of A-type channels mainly comes 
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from electrophysiological and pharmacological 
studies [3]. 
P+Bungarotoxin (,&Butx), a basic protein from 
the venom of the snake Bungarus multicinctus, 
potently inhibits neurotransmitter elease at the 
neuromuscular junction [6]. In the central nervous 
system, ,&Butx is cytotoxic for cholinergic and 
GABA-(y-aminobutyric acid)ergic neurons [7,8]. 
Recent electrophysiological data indicate that the 
mechanism of action of ,&Butx involves binding to 
presynaptic A-type K+ channels [9,10]. In chick 
brain membranes, 1251-labelled &Butx binds 
specifically to a large (430 kDa) membrane protein 
[ 11,121 composed of smaller subunits [ 131. In sup- 
port of its presumed K+ channel nature, the ,&- 
Butx-binding protein exhibits a marked K+ 
dependence for conformational stability upon 
solubilisation [12]. Furthermore, two other K+ 
channel ligands, the facilitatory neurotoxins den- 
drotoxin I (Dtx-I, also called toxin I) from snake 
venom [ 14,151 and mast cell-degranulating (MCD) 
peptide from bee venom [ 16,171, inhibit binding of 
“‘I-,&-Butx to synaptic membrane fractions in a 
non-competitive fashion [ 181. Here we report the 
improved solubilisation and partial purification of 
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the fl-Butx-binding protein from chick brain and 
show that its interactions with Dtx-I and MCD- 
peptide are conserved uring the isolation pro- 
cedure. 
2. MATERIALS AND METHODS 
2. I. Materials 
~-Butx was obtained from Miami Serpentarium (Miami, FL); 
Dtx-I and MCD-peptide were kindly provided by Drs M. 
Hollecker (Heidelberg) and M. Lazdunski (Nice). 
2.2. Preparation of membrane fractions 
Crude synaptic membranes were prepared from brains of 
newly hatched chicken by differential centrifugation as de- 
scribed [11] with minor modifications [19]. The final membrane 
pellet was resuspended in buffer A [20 mM K-Hepes (pH 7.4), 
60 mM KC1, 2 mM Na-EDTA, 0.01% (w/v) NAN3], frozen in 
liquid nitrogen and stored at -70°C. 
2.3. Preparation of detergent extract 
Thawed membrane fractions were adjusted to 0.45 M KC1, 
1.5% (w/v) Triton X-100 and 25070 (w/v) glycerol in buffer A 
and diluted 5-fold to a protein concentration of -~2 mg/ml. 
After addition of protease inhibitors [19] and 2 h of slight stirr- 
ing at 4°C, the suspension was diluted with 2 vols KCl-free buf- 
fer B [buffer A containing 0.8% (w/v) Triton X-100 and 0.2°70 
(w/v) soybean phospholipid] and centrifuged at 48000 x g for 
1 h. The resulting detergent extract was used freshly or stored 
frozen at - 70°C. 
2.4. z251-~-Butx-binding assays 
fl-Butx was labelled with 1251 to an initial specific activity of 
1200-1800 Ci/mmol [11]. Binding to membrane fractions was 
performed as described [18]. Buffer A contained 60 mM KCI 
instead of 115 mM; cellulose-acetate filters were replaced by 
GF/C glass-fiber filters presoaked in 0.3070 (w/v) 
polyethylenimine in 0.135 mM Tris-C1, pH 8.5. ~25I-fl-Butx 
binding to soluble binding sites was determined using a 
modification [19] of  the filter assay described by Bruns et al. 
[20]. Unless indicated otherwise, 1 mM CaC12 and 5 mM 
MnClz were present in the assay. All binding data are corrected 
for nonspecific binding determined in the presence of 240 nM 
unlabelled ~'-But x and represent the mean _ SE (indicated if
larger than size of the symbol) of triplicate determinations. To 
remove leakage toxin, samples eluted from ~'-Butx affinity col- 
umns were incubated with CM-Sephadex C 25 (Pharmacia) 
prior to assay (batch incubation at 5°C for 30-50 h). 
2.5. Preparation of /8-Butx affinity columns 
1-2 mg ~-Butx per ml of gel were coupled to Affigel 15 
(Biorad) according to the manufacturer's ecommendations. 
Coupling was performed in 50 mM Na-Hepes (pH 7.4), 0.3 M 
KC1, 10 mM CaC12 for 1 h at 23°C with 70-90070 efficiency. 
For coupling of~-Butx to Affigel 102 (Biorad), the toxin was 
activated with the water-soluble carbodiimide, EDAC (Biorad) 
[19]. Coupling efficiencies determined by the addition of trace 
amounts of 125I-~'-Butx were 5-15070. 
2.6. Purification of the/?-Butx-binding protein 
Purification of the ~'-Butx-binding protein was performed at 
4°C. 9 ml DEAE Affigel Blue (Biorad) were equilibrated with 
buffer B in a column of 1 × 10cm. Then 30-100ml of 
detergent extract, diluted 2-fold to 75 mM KC1, were loaded on- 
to the column at a flow rate of 14 ml/h. The column was wash- 
ed with buffer B containing 100 mM KCl and eluted with the 
same buffer containing 200 mM KCI. (Elution by a gradient 
from 100 to 300 mM KC1 released the binding activity in a 
single peak around 180 mM KCI.) 
The eluate from the DEAE Affigel Blue column was dialysed 
against buffer C (buffer B containing 1mM CaC12 and 5 mM 
MnCl2 instead of EDTA) and loaded onto a fl-Butx Affigel 102 
column (1 ml) by cyclic overnight application at a flow rate of 
14 ml/h. The column was washed sequentially with buffer C 
and with buffer C containing 100 mM KCI, and then eluted at 
a flow rate of 1 ml/h with buffer B containing 0.3 M KCl. 
The eluate of the ~-Butx affinity column was directly adsorb- 
ed onto a WGA column (1 ml) equilibrated with buffer B by 
cyclic overnight application (flow rate 10 ml/h). The column 
was washed with buffer B and eluted at 0.5 ml/h with buffer B 
containing 25 mM N-acetylglucosamine. 
2.7. Other methods 
Protein was determined by a modification [19] of the 
fluorescamine assay [21] using bovine serum albumin as a stan- 
dard. Samples containing low protein concentrations were con- 
centrated by precipitation according to Wessel and Fliigge [22] 
and resolubilised in 5070 (w/v) SDS. 
3. RESULTS AND DISCUSSION 
3.1. Solubilisation of the/3-Butx-binding protein 
Previous experiments have shown that the 
presence of K ÷ is required for solubilisation of 
native 125I-~?-Butx-binding sites [12]. Here, the effi- 
ciency of solubilisation was increased from about 
35 to >90% by using high ionic strength condi- 
tions (0.45 M KC1). Furthermore, addition of 
glycerol to the detergent extract markedly stabil- 
ized soluble 125I-tS-Butx-binding sites (half-life 
about 2 weeks at 5°C, not shown). Under these 
conditions the loss of binding activity upon freez- 
ing at -70°C was negligible. 
Scatchard analysis howed that the affinity of 
125I-fl-Butx binding to detergent extract was 2-fold 
lower than that to membranes (Kd about 500 pM 
for detergent extract, and 250 pM for membranes; 
see also fig.2). 
3.2. t25I-~-Butx binding to the solubilised binding 
protein: effect of ionic strength and divalent 
cations 
Previous studies of 125I-~'-Butx binding to 
detergent extract employed a tedious gel-filtration 
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assay procedure [12]. Here, this method was 
replaced by polyethylenimine filter binding which 
has been reported to recover nearly quantitatively 
other receptor sites [20]. The new assay not only 
gave higher specific binding values and a low 
unspecific filter binding signal, but also proved to 
be highly reproducible (SE of triplicate determina- 
tions l-4%). 
1251-,8-Butx binding to both detergent extract 
and membranes was strongly affected by the ionic 
strength (I) of the assay buffer (fig.1). Under the 
binding conditions used earlier [ 11,121, i.e. in the 
presence of 1 mM Cazf, a reduction of the KC1 
concentration from 115 mM (Z = 0.142) to 39 mM 
(Z = 0.066) increased specific binding to detergent 
extract by 4-5-fold. Scatchard analysis showed 
that this increase was mainly due to an increased 
apparent affinity (lower Kd) Of the toxin rather 
than to a major alteration in the maximal number 
(Bmax) of binding sites (fig.1, inset). Similar find- 
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Fig. 1. Effect of different ionic strength conditions and Mn*+ on 
‘2SI-&Butx binding. Binding to detergent extract was 
determined at different KC1 concentrations (14-135 mM) in the 
presence of 1 mM CaCls without (0) or with 5 mM MgCls 
(v), or with 5 mM MnC12 (A). For comparison, membrane 
binding (dashed lines) was tested at 60, 115 and 260 mM KCI 
in the presence of 1 mM Cat& without (x) or with 5 mM 
MgCla added (+). Inset: Scatchard plot of ‘251-/3-Butx binding 
to detergent extract. Assay conditions were: 115 mM KCI, 
1 mM CaClz (0); same but plus 2.5 mM MnC12 (A); 39 mM 
KCI, 1 mM CaC12 (0). 
ings have also been made for other polypeptide 
ligands [23]. 
The inhibitory effect of high salt concentrations 
on ‘251-&Butx binding was partially overcome by 
the addition of the divalent cation, Mn2+ (fig.1). 
This cation increased toxin binding to both 
detergent extract and membranes over the whole 
ionic strength range tested; the effect was, 
however, much more pronounced with the 
solubilised protein. Analysis of binding data 
revealed the increase of toxin binding to detergent 
extract by Mn2+ to result from a 2-fold decrease in 
apparent Kd (fig.1, inset). 
Another divalent cation, Ca2+, is known to bind 
to &Butx with a Kd of 0.1-0.2 mM, thus altering 
the toxin’s conformation [6] and its affinity for 
neuronal membranes [18]. The effect of Mn2+, 
however, appears not to be mediated via this 
divalent cation-binding site of ,&Butx, but rather 
by interaction with its membrane receptor. First, 
Mn2+ affected toxin binding to membranes much 
less than to the soluble protein (see fig. 1). Second, 
Mn2+ could not be replaced by other divalent 
cations, i.e. Mg2+ or Sr2+, the latter of which is 
known to substitute for the Ca2+ requirements of 
the snake toxin [6,11,24]. 
From these data, standard conditions for the 
determination of 1251-&Butx binding were 
established. As low ionic strength buffers in- 
creased unspecific filter binding of the labelled tox- 
in, 60 mM KCl, 1 mM Ca2+ and 5 mM Mn2+ (I = 
0.102) were routinely included in the binding 
assay. 
3.3. Purification of the @-Butx-binding protein 
In initial experiments, two types of fl-Butx af- 
finity resins were tested for retention of soluble ,8- 
Butx-binding sites. First, P-Butx was coupled to 
Affigel 15 via amino groups. The resulting resin 
contained about 15 nmol toxin per ml; its binding 
capacity was, however, only about 1.5 pmol/ml of 
toxin-binding sites. Derivatisation of Affigel 102 
with EDAC-activated ,&Butx produced gels of 
slightly better capacity, although coupling efficien- 
cies were 5-lo-times lower. A gel substituted with 
6 nmol/ml of toxin retained 6-9 pmol of binding 
sites/ml. 
From both types of gels, bound fi-Butx-binding 
sites were efficiently eluted by 0.2-0.35 M KCl, 
but not by withdrawal of divalent cations with 
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Table 1 
Purification of the ,&Butx-binding protein 
Purification 
step 
Total 
protein 
(mg) 
‘Z51-,&Butx Specific Yield Purifi- 
bounda activity (Q) cation 
(fmol) (fmol/mg (-fold) 
protein) 
Detergent extract 52.5 2090 40 100 1 
DEAE Affigel 
Blue eluate 8.0 1370 212 66 5.3 
,&Butx Affigel 
102 eluate 0.24 478 1990 23 50 
WGA column 
eluate 0.075 400 5330 19 134 
a Binding was determined under nonsaturating conditions (200 pM ‘Z51-~-Butx). 
Binding values are thus lower than those calculated from Scatchard plots 
EDTA. Usually, a 20-40-fold enrichment in 125I- 
,&Butx-binding sites was obtained (not shown). As 
,&Butx Affigel 102 exhibited a higher capacity and 
yield of binding sites, this resin was chosen for 
enriching larger amounts of the ,&-Butx-binding 
protein. 
As the first step in a scaled-up purification pro- 
cedure, detergent extract was concentrated on a 
DEAE Affigel Blue column which retained > 80% 
of the binding sites present in the extract. About 
80% of these sites were recovered upon salt elution 
with a 5-fold enrichment in specific 1251-,&Butx- 
binding activity. Subsequent chromatography on a 
,&Butx Affigel 102 column resulted in a further 
lo-fold purification. After lectin affinity 
chromatography on WGA Sepharose, an overall 
1 OO- 150-fold purification of the P-Butx-binding 
protein, was achieved (table 1). 
Purification did not significantly affect the 1251- 
P-Butx-binding affinity of the toxin-binding pro- 
tein (fig.2). For three different preparations, Scat- 
chard analysis gave mean Kd values of 495 f 165 
and 415 + 200 pM, and B,,, values of 0.17 -t 0.05 
and 14.3 f 2.3 pmol/mg for detergent extracts and 
WGA column eluates, respectively. 
From these data, and considering the about 
3-fold enrichment of ‘2’I-,&Butx-binding sites dur- 
ing membrane preparation, the ,&Butx-binding 
protein was purified about 300-fold over the tissue 
homogenate. This value is much lower than ex- 
pected for a pure K+-channel protein preparation. 
Assuming a molecular mass of 430 kDa [12], a 
68 
theoretical toxin-binding activity of 2.3 nmol/mg 
protein is expected. Although inactivation of 
binding sites during lectin affinity chromatography 
and non-quantitative filter binding assays may 
mask higher purification factors (for discussions 
see [25]), further purification procedures certainly 
are required for establishing the polypeptide com- 
position of the ,&Butx-binding protein. 
etergent extract 
0.00 
0 IO 20 30 40 50 60 
1251-p-Butx bound [pm] 
Fig.2. Scatchard analysis of ‘251-@Butx binding (concentration 
range 0.02-2.5 nM) to detergent extract and WGA column 
eluate. In this experiment, Kd values determined with detergent 
extract and WGA column eluate were 580 and 300 pM, B,,, 
values 0.24 and 14 pmol/mg protein, and Hill coefficients (n) 
1 .Ol and 0.99, respectively. 
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3 A. Pharmacology of the solubilised and partially 
purified P-B&x-binding protein 
Detergent extracts and WGA column eluates 
were tested for interaction with two other putative 
K+ channel ligands, Dtx-I and MCD-peptide. Fig.3 
shows the inhibition profiles of ‘251-@Butx binding 
to a WGA column eluate by unlabelled P-Butx, 
Dtx-I and MCD-peptide. All toxins efficiently an- 
tagonized binding of the radiolabelled ligand. Ki 
values are summarized in table 2 and compared to 
those obtained with membrane fractions. It is evi- 
dent that the affinity of all three toxins is unaltered 
or even increased upon solubilisation and purifica- 
tion. This is particularly pronounced in the case of 
MCD-peptide, where Ki values of 180 nM [ 181 and 
60 nM (assay conditions of this study, see table 2) 
are observed with crude synaptic membranes, and 
l-5 nM after solubilisation and partial purifica- 
tion, respectively. 
The observation that Dtx-I and MCD-peptide 
binding sites copurify with the&Butx-binding pro- 
tein strongly supports the notion [18] that binding 
of these toxins indeed occurs at allosteric sites of 
the same membrane protein rather than at dif- 
ferent A-type K+ channel species. On the other 
V MCD-peptide 
--oo ” -il _io -9 -8 -3 -6 
log M [inhibitor] 
Fig.3. Inhibition of ‘251-/3-Butx binding to WGA column eluate 
by,&Butx, Dtx-I and MCD-peptide. The inhibitors were diluted 
in buffer A containing 0.2% (w/v) bovine serum albumin and 
0.01% (w/v) Triton X-100 and mixed with ‘251-fl-Butx prior to 
addition of the WGA column eluate. Control binding was 
4.85 f 0.10 pmol/mg protein. From the concentrations causing 
half-maximal inhibition (Kso) the apparent Ki values were 
calculated according to Ki = &o/(L/Kd + 1) [30]. 
Table 2 
Inhibition of ‘251-fl-Butx binding by presynaptic neurotoxins 
Toxin Ki (nM) 
Membranes Detergent WGA column 
extract eluate 
,%Butx 0.05 + 0.01 0.088 + 0.024 0.046 f 0.020 
Dtx-I 0.33 + 0.07 0.76 + 0.18 0.31 * 0.07 
MCD-peptide 57 f 20 4.6 f 0.5 1.6 k 0.4 
Values represent means + SE of three independent purifications 
except in the case of membranes where only a single experiment 
was performed 
hand, both ’ binding studies [26] and 
chromatographic separation procedures [27] have 
provided clear evidence for the existence of 
physically separate high-affinity binding sites for 
1251-labelled Dtx-I in rat which exhibit high and 
low affinities for &Butx. Furthermore, affinity 
purification of a Dtx-I and MCD-peptide binding 
protein from rat brain has been reported recently 
[28]. Interestingly, 1251-Dtx-I binding to this 
putative K+ channel is inhibited by @-Butx with an 
affinity (Ki 10 nM as calculated from 1271) at least 
lo-fold lower than that determined by direct 
radioligand binding to chick and rat brain mem- 
branes [ 181. Thus, the &Butx-binding site in- 
vestigated here probably represents only one 
member of a family of toxin-sensitive A-type Kf 
channels which differ in their relative affinities for 
&Butx, Dtx-I and MCD-peptide. This interpreta- 
tion is consistent with electrophysiological data on 
sensory and sympathetic neurons which indicate 
striking differences in the neurotoxin sensitivity of 
their A-type K+ currents [ 171. Moreover, a recent 
Northern blot analysis has also demonstrated con- 
siderable heterogeneity in putative A-type Kf 
channel mRNAs in rat brain [29]. 
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